{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:01:06Z","timestamp":1777471266194,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00213-015-4036-5","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T05:03:40Z","timestamp":1438232620000},"page":"3763-3772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD"],"prefix":"10.1007","volume":"232","author":[{"given":"Ming-Tao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Mei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"4036_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, Arlington"},{"key":"4036_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44\u201379","journal-title":"Prog Neurobiol"},{"key":"4036_CR3","first-page":"771","volume":"84","author":"WH Bergstom","year":"1952","unstructured":"Bergstom WH, Carzoli RF, Lombroso C, Davidson DT, Wallace WM (1952) Observations on the metabolic and clinical effects of carbonic-anhydrase inhibitors in epileptics. AMA Am J Dis Child 84:771\u2013772","journal-title":"AMA Am J Dis Child"},{"key":"4036_CR4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00415-010-5603-7","volume":"257","author":"PE Bermejo","year":"2010","unstructured":"Bermejo PE, Ruiz-Huete C, Anciones B (2010) Zonisamide in managing impulse control disorders in Parkinson\u2019s disease. J Neurol 257:1682\u20131685","journal-title":"J Neurol"},{"key":"4036_CR5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1101\/lm.033613.113","volume":"21","author":"SA Carmack","year":"2014","unstructured":"Carmack SA, Howell KK, Rasaei K, Reas ET, Anagnostaras SG (2014) Animal model of methylphenidate\u2019s long-term memory-enhancing effects. Learn Mem 21:82\u201389","journal-title":"Learn Mem"},{"key":"4036_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0014-2999(94)00492-7","volume":"264","author":"I Chaudieu","year":"1994","unstructured":"Chaudieu I, St-Pierre JA, Quirion R, Boksa P (1994) GABAA receptor-mediated inhibition of N-methyl-d-aspartate-evoked [3H]\u00a0dopamine release from mesencephalic cell cultures. Eur J Pharmacol 264:361\u2013369","journal-title":"Eur J Pharmacol"},{"key":"4036_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jcpp.12036","volume":"54","author":"S Cortese","year":"2013","unstructured":"Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J (2013) Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry 54:227\u2013246","journal-title":"J Child Psychol Psychiatry"},{"key":"4036_CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2012.03.065","volume":"215","author":"JW Dalley","year":"2012","unstructured":"Dalley JW, Roiser JP (2012) Dopamine, serotonin and impulsivity. Neuroscience 215:42\u201358","journal-title":"Neuroscience"},{"key":"4036_CR9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","volume":"69","author":"JW Dalley","year":"2011","unstructured":"Dalley JW, Everitt BJ, Robbins TW (2011) Impulsivity, compulsivity, and top-down cognitive control. Neuron 69:680\u2013694","journal-title":"Neuron"},{"key":"4036_CR10","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","volume":"69","author":"N Campo Del","year":"2011","unstructured":"Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder. Biol Psychiatry 69:e145\u2013e157","journal-title":"Biol Psychiatry"},{"key":"4036_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1866-1955-4-19","volume":"4","author":"GS Dichter","year":"2012","unstructured":"Dichter GS, Damiano CA, Allen JA (2012) Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord 4:19","journal-title":"J Neurodev Disord"},{"key":"4036_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0014-2999(74)90110-1","volume":"28","author":"WD Gray","year":"1974","unstructured":"Gray WD, Rauh CE (1974) The anticonvulsant action of the carbonic anhydrase inhibitor methazolamide: possible involvement of a noradrenergic mechanism. Eur J Pharmacol 28:42\u201354","journal-title":"Eur J Pharmacol"},{"key":"4036_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainresbull.2013.03.004","volume":"96","author":"Z Jones","year":"2013","unstructured":"Jones Z, Dafny N (2013) Dose response effect of methylphenidate on ventral tegmental area neurons and animal behavior. Brain Res Bull 96:86\u201392","journal-title":"Brain Res Bull"},{"key":"4036_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0387-7604(02)00003-7","volume":"24","author":"F Katayama","year":"2002","unstructured":"Katayama F, Miura H, Takanashi S (2002) Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies. Brain Dev 24:150\u2013154","journal-title":"Brain Dev"},{"key":"4036_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0920-1211(99)00010-8","volume":"35","author":"Y Kawata","year":"1999","unstructured":"Kawata Y, Okada M, Murakami T, Mizuno K, Wada K, Kondo T, Kaneko S (1999) Effects of zonisamide on K+ and Ca2+ evoked release of monoamine as well as K+ evoked intracellular Ca2+ mobilization in rat hippocampus. Epilepsy Res 35:173\u2013182","journal-title":"Epilepsy Res"},{"key":"4036_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4062\/biomolther.2012.20.1.125","volume":"20","author":"P Kim","year":"2012","unstructured":"Kim P, Choi I, Pena IC, Kim HJ, Kwon KJ, Park JH, Han SH, Ryu JH, Cheong JH, Shin CY (2012) A simple behavioral paradigm to measure impulsive behavior in an animal model of attention deficit hyperactivity disorder (ADHD) of the spontaneously hypertensive rats. Biomol Ther (Seoul) 20:125\u2013131","journal-title":"Biomol Ther (Seoul)"},{"key":"4036_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nn1182","volume":"7","author":"SR Laviolette","year":"2004","unstructured":"Laviolette SR, Gallegos RA, Henriksen SJ, van der Kooy D (2004) Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area. Nat Neurosci 7:160\u2013169","journal-title":"Nat Neurosci"},{"key":"4036_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1212\/WNL.0b013e318206ca02","volume":"76","author":"DW Loring","year":"2011","unstructured":"Loring DW, Williamson DJ, Meador KJ, Wiegand F, Hulihan J (2011) Topiramate dose effects on cognition: a randomized double-blind study. Neurology 76:131\u2013137","journal-title":"Neurology"},{"key":"4036_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/rns.2011.024","volume":"22","author":"A Meneses","year":"2011","unstructured":"Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Gallegos-Cari A, Castillo C (2011) Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview. Rev Neurosci 22:365\u2013371","journal-title":"Rev Neurosci"},{"key":"4036_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1358\/dot.2010.46.4.1490077","volume":"46","author":"M Murata","year":"2010","unstructured":"Murata M (2010) Zonisamide: a new drug for Parkinson\u2019s disease. Drugs Today 46:251\u2013258","journal-title":"Drugs Today"},{"key":"4036_CR21","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals. National Academies Press, Washington, DC"},{"key":"4036_CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","volume":"22","author":"M Okada","year":"1995","unstructured":"Okada M, Kaneko S, Hirano T, Mizuno K, Kondo T, Otani K, Fukushima Y (1995) Effects of zonisamide on dopaminergic system. Epilepsy Res 22:193\u2013205","journal-title":"Epilepsy Res"},{"key":"4036_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neures.2010.10.001","volume":"69","author":"NE Paterson","year":"2011","unstructured":"Paterson NE, Ricciardi J, Wetzler C, Hanania T (2011) Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neurosci Res 69:41\u201350","journal-title":"Neurosci Res"},{"key":"4036_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-011-2584-x","volume":"219","author":"T Robbins","year":"2012","unstructured":"Robbins T, Curran H, de Wit H (2012) Special issue on impulsivity and compulsivity. Psychopharmacology (Berl) 219:251\u2013252","journal-title":"Psychopharmacology (Berl)"},{"key":"4036_CR25","doi-asserted-by":"crossref","unstructured":"Russell VA (2011) Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci Chapter 9: Unit9 35","DOI":"10.1002\/0471142301.ns0935s54"},{"key":"4036_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(99)00058-5","volume":"24","author":"T Sagvolden","year":"2000","unstructured":"Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD). Neurosci Biobehav Rev 24:31\u201339","journal-title":"Neurosci Biobehav Rev"},{"key":"4036_CR27","first-page":"301","volume-title":"Behavioral neuroscience of attention deficit hyperactivity disorder and its treatment (current topics in behavioral neurosciences)","author":"T Sagvolden","year":"2012","unstructured":"Sagvolden T, Johansen E (2012) Rat models of ADHD. In: Stanford C, Tannock R (eds) Behavioral neuroscience of attention deficit hyperactivity disorder and its treatment (current topics in behavioral neurosciences). Springer Press, Berlin, pp 301\u2013315"},{"key":"4036_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-9081-4-3","volume":"4","author":"T Sagvolden","year":"2008","unstructured":"Sagvolden T, Xu T (2008) l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of attention-deficit\/hyperactivity disorder (ADHD). Behav Brain Funct 4:3","journal-title":"Behav Brain Funct"},{"issue":"1003\u20131019","key":"4036_CR29","volume":"51","author":"C Scassellati","year":"2012","unstructured":"Scassellati C, Bonvicini C, Faraone SV, Gennarelli M (2012) Biomarkers and attention-deficit\/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatr 51(1003\u20131019), e20","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"key":"4036_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1741-7015-10-99","volume":"10","author":"M Shaw","year":"2012","unstructured":"Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE (2012) A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 10:99","journal-title":"BMC Med"},{"key":"4036_CR31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.biopsych.2004.09.008","volume":"57","author":"EJ Sonuga-Barke","year":"2005","unstructured":"Sonuga-Barke EJ (2005) Causal models of attention-deficit\/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57:1231\u20131238","journal-title":"Biol Psychiatry"},{"key":"4036_CR32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004583-199604000-00008","volume":"35","author":"T Spencer","year":"1996","unstructured":"Spencer T, Biederman J, Wilens T, Harding M, O\u2019Donnell D, Griffin S (1996) Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409\u2013432","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4036_CR33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-3565(24)29621-X","volume":"297","author":"MK Sun","year":"2001","unstructured":"Sun MK, Alkon DL (2001) Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther 297:961\u2013967","journal-title":"J Pharmacol Exp Ther"},{"key":"4036_CR34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00213-013-3002-3","volume":"227","author":"R Ting-A-Kee","year":"2013","unstructured":"Ting-A-Kee R, Vargas-Perez H, Mabey JK, Shin SI, Steffensen SC, van der Kooy D (2013) Ventral tegmental area GABA neurons and opiate motivation. Psychopharmacology (Berl) 227:697\u2013709","journal-title":"Psychopharmacology (Berl)"},{"key":"4036_CR35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1440-1819.2001.00869.x","volume":"55","author":"M Tominaga","year":"2001","unstructured":"Tominaga M, Nagatomo I, Uchida M, Hashiguchi W, Akasaki Y, Takigawa M (2001) Alterations of nitric oxide and monoamines in the brain of the EL mouse treated with phenobarbital and zonisamide. Psychiatry Clin Neurosci 55:311\u2013318","journal-title":"Psychiatry Clin Neurosci"},{"key":"4036_CR36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-2999(73)90137-4","volume":"21","author":"ML Torchiana","year":"1973","unstructured":"Torchiana ML, Lotti VJ, Stone CA (1973) The anticonvulsant effect of carbonic anhydrase inhibitors in mice\u2014a noradrenergic mechanism of action. Eur J Pharmacol 21:343\u2013349","journal-title":"Eur J Pharmacol"},{"key":"4036_CR37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2013.01.033","volume":"702","author":"M Umehara","year":"2013","unstructured":"Umehara M, Ago Y, Fujita K, Hiramatsu N, Takuma K, Matsuda T (2013a) Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats. Eur J Pharmacol 702:250\u2013257","journal-title":"Eur J Pharmacol"},{"key":"4036_CR38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/FBP.0b013e3283633648","volume":"24","author":"M Umehara","year":"2013","unstructured":"Umehara M, Ago Y, Kawanai T, Fujita K, Hiramatsu N, Takuma K, Matsuda T (2013b) Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit\/hyperactivity disorder, through alpha2-adrenoceptor activation. Behav Pharmacol 24:328\u2013331","journal-title":"Behav Pharmacol"},{"key":"4036_CR39","first-page":"297","volume":"128","author":"A Verrotti","year":"2013","unstructured":"Verrotti A, Loiacono G, Di Sabatino F, Zaccara G (2013) The adverse event profile of zonisamide: a meta-analysis. Acta Neurol Scand 128:297\u2013304","journal-title":"Acta Neurol Scand"},{"key":"4036_CR40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2261-12-41","volume":"12","author":"AN Westover","year":"2012","unstructured":"Westover AN, Halm EA (2012) Do prescription stimulants increase the risk of adverse cardiovascular events?: a systematic review. BMC Cardiovasc Disord 12:41","journal-title":"BMC Cardiovasc Disord"},{"key":"4036_CR41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s13311-012-0135-8","volume":"9","author":"EG Willcutt","year":"2012","unstructured":"Willcutt EG (2012) The prevalence of DSM-IV attention-deficit\/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9:490\u2013499","journal-title":"Neurotherapeutics"},{"key":"4036_CR42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1113\/jphysiol.2006.124099","volume":"580","author":"C Xiao","year":"2007","unstructured":"Xiao C, Zhou C, Li K, Ye J-H (2007) Presynaptic GABAA receptors facilitate GABAergic transmission to dopaminergic neurons in the ventral tegmental area of young rats. J Physiol 580:731\u2013743","journal-title":"J Physiol"},{"key":"4036_CR43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuropharm.2012.11.031","volume":"67","author":"MT Yang","year":"2013","unstructured":"Yang MT, Chien WL, Lu DH, Liou HC, Fu WM (2013) Acetazolamide impairs fear memory consolidation in rodents. Neuropharmacology 67:412\u2013418","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4036-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-4036-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4036-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:20:30Z","timestamp":1748550030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-4036-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":43,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["4036"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-4036-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}